FDA Adverse Event Malfunction Summary report: N

VIDAS® MEASLES IGG ASSAY

MDR report key: 5364749 · Received January 13, 2016

Report

Report Number
3002769706-2016-00007
Event Type
Malfunction
Date Received
January 13, 2016
Report Date
October 16, 2015
Manufacturer
BIOMERIEUX SA
Product Code
LJB
PMA / PMN Number
EXEMPT
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CO, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

DEVICE NOT RETURNED TO MANUFACTURER.

Additional Manufacturer Narrative · 1

BIOMÉRIEUX INTERNAL INVESTIGATION WAS CONDUCTED. HOWEVER, THE CUSTOMER DID NOT COMPLY WITH BIOMÉRIEUX REQUEST FOR SAMPLE SUBMITTAL AND THE REFERENCED PRODUCT LOT WAS ALREADY EXPIRED. ANALYSIS OF THE MANUFACTURING QC BATCH RECORD SHOWED NO ABNORMALITY. AS INDICATED IN THE INSTRUCTIONS FOR USE, VIDAS® MEASLES IGG PERFORMANCE DOES NOT CLAIM 100% IN TERM OF SPECIFICITY OR SENSITIVITY. VIDAS® MEASLES IGG AND ARUP USE DIFFERENT TESTING METHODS; THEY ARE QUALITATIVE ELFA TEST AND SEMI-QUANTITATIVE CHEMILUMINESCENT TEST, RESPECTIVELY. WITHOUT THE ARUP PERFORMANCE SPECIFICATIONS (SENSITIVITY AND SPECIFICITY) AND THE LACK OF THIRD CONFIRMATORY METHOD, IT IS NOT POSSIBLE TO DETERMINE WHICH RESULT IS CORRECT. THE INVESTIGATION CONCLUDED THAT NO PRODUCT PERFORMANCE ISSUE WAS CONFIRMED FOR THE REFERENCED LOT OF VIDAS® MEASLES IGG ASSAY.

Description of Event or Problem · 1

A CUSTOMER IN THE UNITED STATES REPORTED A DISCREPANCY IN RESULTS WITH THE VIDAS EASLES IGG TEST. THERE IS NO INDICATION OR REPORT FROM THE HOSPITAL TO BIOMERIEUX THAT THE ASSOCIATED INVALID AVIDITY RESULTS LED TO ANY ADVERSE EVENT RELATED TO A PATIENT'S STATE OF HEALTH. SUBMITTAL OF THE PATIENT SAMPLE HAS BEEN REQUESTED. BIOMERIEUX INVESTIGATION WILL BE INITIATED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
21829 VIDAS® MEASLES IGG ASSAY VIDAS® MEASLES IGG ASSAY LJB BIOMERIEUX SA 1003574790

Patients

Seq Age Sex Outcome Treatment
1